Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

NCT03586297 ·Status: COMPLETED

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

NCT03667417 ·Status: RECRUITING

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

NCT01306188 ·Status: COMPLETED

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 ·Status: RECRUITING

Microbiome Immunotherapy Neoadjuvant Assessment

NCT06709651 ·Status: RECRUITING

Study of Metabolites Markers in Adjuvant Breast Cancer

NCT03367208 ·Status: COMPLETED

Triple Negative Breast Cancer Biomarker Study

NCT01111175 ·Status: COMPLETED

Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study.

NCT06026631 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

NCT04012229 ·Status: COMPLETED

Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

NCT02530008 ·Status: ACTIVE_NOT_RECRUITING

The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

NCT06318507 ·Status: RECRUITING

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

NCT01513408 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer

NCT04133077 ·Status: RECRUITING ·Phase: NA

The Immune System's Response to Young Women's Breast Cancer

NCT01503190 ·Status: RECRUITING

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

NCT04999826 ·Status: COMPLETED

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 ·Status: UNKNOWN

Triple-negative Breast Cancer: a New Perspective on Biomarkers

NCT03539965 ·Status: COMPLETED

Reproductive Health in Breast Cancer Survivor

NCT06756802 ·Status: ACTIVE_NOT_RECRUITING

Role of the Immune Environment in Response to Therapy in Breast Cancer

NCT05396612 ·Status: RECRUITING

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

NCT05910710 ·Status: RECRUITING

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

NCT01460186 ·Status: COMPLETED ·Phase: NA

Pregnant Exposure to Persistent Organic Pollutants

NCT03419026 ·Status: COMPLETED

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer

NCT04145960 ·Status: UNKNOWN